Aan Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 31-08-2024
- Paid Up Capital ₹ 3.24 M
as on 31-08-2024
- Company Age 30 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 50.05 Cr
as on 31-08-2024
- Satisfied Charges ₹ 20.28 Cr
as on 31-08-2024
- Revenue -2.58%
(FY 2023)
- Profit 49.79%
(FY 2023)
- Ebitda 42.07%
(FY 2023)
- Net Worth 182.42%
(FY 2023)
- Total Assets 56.23%
(FY 2023)
About Aan Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 3.24 M.
The company currently has active open charges totaling ₹50.05 Cr. The company has closed loans amounting to ₹20.28 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ashwin Shah, Chhayaben Shah, and Maulik Shah serve as directors at the Company.
- CIN/LLPIN
U24231GJ1994PTC023223
- Company No.
023223
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Oct 1994
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Aan Pharma?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashwin Shah  | Director | 07-Oct-1994 | Current |
| Chhayaben Shah | Director | 07-Oct-1994 | Current |
| Maulik Shah | Director | 15-Dec-2017 | Current |
Financial Performance and Corporate Structure Insights of Aan Pharma.
Aan Pharma Pvt Ltd, for the financial year ended 2023, experienced Minor drop in revenue, with a 2.58% decrease. The company also saw a substantial improvement in profitability, with a 49.79% increase in profit. The company's net worth Soared by an impressive increase of 182.42%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aan Pharma?
Unlock access to Aan Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Aditri Marketing Private LimitedActive 13 years 3 monthsAshwin Shah and Maulik Shah are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 04 Jan 2024 | ₹19.74 Cr | Open |
Hdfc Bank Limited Creation Date: 01 Jan 2024 | ₹0.68 M | Open |
Bank Of India Creation Date: 29 Nov 2023 | ₹8.30 Cr | Open |
How Many Employees Work at Aan Pharma?
Aan Pharma has a workforce of 6 employees as of Aug 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aan Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aan Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
